Average Co-Inventor Count = 5.63
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (29 from 2,078 patents)
2. Boehringer Ingelheim Pharmaceuticals, Inc. (3 from 276 patents)
3. 3-dimensional Pharmaceuticals, Inc. (3 from 76 patents)
4. Other (2 from 832,843 patents)
5. Ortho-mcneil Pharmaceutical Corp. (2 from 363 patents)
39 patents:
1. 10988433 - Cyclohexyl GPR40 agonists for the treatment of type II diabetes
2. 10662170 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
3. 10131648 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
4. 10106553 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
5. 9920040 - GPR40 agonists for the treatment of type II diabetes
6. 9908873 - GPR40 agonists for the treatment of type II diabetes
7. 9856245 - GPR40 agonists for the treatment of type II diabetes
8. 9790198 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
9. 9718820 - Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators
10. 9688642 - Substituted pyrazines as GPR40 agonists
11. 9409915 - Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
12. 9249163 - PDE10a inhibitors for the treatment of type II diabetes
13. 9193736 - PDE 10a inhibitors for the treatment of type II diabetes
14. 9067898 - Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes
15. 9023846 - Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators